These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27633869)

  • 41. Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.
    Niu J; Zeng M; Wang Y; Liu J; Li H; Wang S; Zhou X; Wang J; Li Y; Hou F; Zhu J
    BMC Cardiovasc Disord; 2020 Jun; 20(1):292. PubMed ID: 32539749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Layer-specific speckle tracking analysis of left ventricular systolic function and synchrony in maintenance hemodialysis patients.
    Liu C; Yan ZN; Fan L; Huang J; Shen D; Song XT
    BMC Cardiovasc Disord; 2020 Jan; 20(1):126. PubMed ID: 32160879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial T1 Values at 1.5 T: Normal Values for General Electric Scanners and Sex-Related Differences.
    Meloni A; Martini N; Positano V; D'Angelo G; Barison A; Todiere G; Grigoratos C; Barra V; Pistoia L; Gargani L; Ripoli A; Pepe A
    J Magn Reson Imaging; 2021 Nov; 54(5):1486-1500. PubMed ID: 33848021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.
    Zhao L; Li S; Zhang C; Tian J; Lu A; Bai R; An J; Greiser A; Huang J; Ma X
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):30. PubMed ID: 33745456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
    Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.
    Li A; Ruh A; Berhane H; Robinson JD; Markl M; Rigsby CK
    Pediatr Radiol; 2020 Feb; 50(2):168-179. PubMed ID: 31659403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping.
    Antlanger M; Aschauer S; Kammerlander AA; Duca F; Säemann MD; Bonderman D; Mascherbauer J
    Sci Rep; 2018 Apr; 8(1):5572. PubMed ID: 29615750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early detection of myocardial involvement by T
    Yu L; Sun J; Sun J; Li J; Dong Y; Zhou X; Greiser A; Han Y; Zhang Q; Xie Q; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):415-422. PubMed ID: 29328539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis.
    Chin CWL; Everett RJ; Kwiecinski J; Vesey AT; Yeung E; Esson G; Jenkins W; Koo M; Mirsadraee S; White AC; Japp AG; Prasad SK; Semple S; Newby DE; Dweck MR
    JACC Cardiovasc Imaging; 2017 Nov; 10(11):1320-1333. PubMed ID: 28017384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.
    Nii M; Ishida M; Dohi K; Tanaka H; Kondo E; Ito M; Sakuma H; Ikeda T
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):52. PubMed ID: 30068369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of cardiac functions after hemodialysis session in pediatric patients with end-stage renal disease: conventional echocardiography and two-dimensional speckle tracking study.
    Rakha S; Hafez M; Bakr A; Hamdy N
    Pediatr Nephrol; 2020 May; 35(5):861-870. PubMed ID: 31925535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffuse Myocardial Fibrosis in Children After Heart Transplantations: A Magnetic Resonance T1 Mapping Study.
    Riesenkampff E; Chen CK; Kantor PF; Greenway S; Chaturvedi RR; Yoo SJ; Greiser A; Dipchand AI; Grosse-Wortmann L
    Transplantation; 2015 Dec; 99(12):2656-62. PubMed ID: 26102614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial T1 rho mapping of patients with end-stage renal disease and its comparison with T1 mapping and T2 mapping: A feasibility and reproducibility study.
    Wang L; Yuan J; Zhang SJ; Gao M; Wang YC; Wang YX; Ju S
    J Magn Reson Imaging; 2016 Sep; 44(3):723-31. PubMed ID: 26889749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
    Avitzur N; Satriano A; Afzal M; Narous M; Mikami Y; Hansen R; Dobko G; Flewitt J; Lydell CP; Howarth AG; Chow K; Fine NM; White JA
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1937-1946. PubMed ID: 30014362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease　- Comparison With Targeted Left Ventricular Myocardial Biopsy.
    Kockova R; Kacer P; Pirk J; Maly J; Sukupova L; Sikula V; Kotrc M; Barciakova L; Honsova E; Maly M; Kautzner J; Sedmera D; Penicka M
    Circ J; 2016 Apr; 80(5):1202-9. PubMed ID: 26984717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.
    Pagano JJ; Chow K; Khan A; Michelakis E; Paterson I; Oudit GY; Thompson RB
    PLoS One; 2016; 11(6):e0157565. PubMed ID: 27305064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.